Asia Pacific Markets for Facial Injectables 2010

Asia Pacific Markets for Facial Injectables 2010 published by Millennium Research Group in December, 2009. This report price starts from US $ 4897.

Introduction

Abstract

This report covers: Australia, New Zealand, Japan, China, and Taiwan

The Asia Pacific facial injectable market includes botulinum toxin (BTX), hyaluronic acid (HA) dermal fillers, particle and polymer fillers (PPFs), and collagen fillers sold in Australasia (Australia and New Zealand), Japan, China (including Hong Kong), and Taiwan. This market will grow strongly through 2014 due to increased physician adoption of profitable facial injectable treatments in their practices and growing patient demand for less invasive cosmetic procedures. Media reports have magnified certain adverse events associated with BTX and PPF treatments, which will discourage some individuals from seeking these procedures. Furthermore, many patients are deterred by the cost and inconvenience of repeat BTX and HA dermal filler treatments - in some cases, two to three visits are required for optimal results. The strict regulatory approval processes in some countries will also impede new product releases. Nonetheless, a high aesthetic consciousness in the Asia Pacific region will fuel continued demand for cosmetic procedures, including facial injectable treatments. In certain countries, physical appearance is taken into consideration when hiring new employees. Given the tight labor market during the global economic recession, a number of individuals will seek facial injectable treatment to enhance their appeal as job candidates. The large pool of patients in the Asia Pacific region represents a significant opportunity for revenue potential in the facial injectable market

Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
• Facial Injectable Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various facial injectable market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

In addition to Steps 1 through 4 (as outlined above), the following “bottom-up” methodology was followed in developing forecast assumptions for this report.

A comprehensive breakdown of various facial injectable procedures was prepared using data from several sources including professional associations, government statistics, and private research/media sources. Industry experts and practitioners were consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through 10-Ks and other sources were compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and in-house experts, year-by-year growth rates and average selling prices were applied individually to each subcategory to derive forecasts. These estimates were cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings were compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 ASIA PACIFIC FACIAL INJECTABLE MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Key Report Updates
  • 1.2.2 Economic Assumptions for the Forecast Period
  • 1.2.3 Product Overview
  • 1.2.4 Procedures
  • 1.2.5 Market Forecast
    • 1.2.5.1 Australasian Facial Injectable Market
    • 1.2.5.2 Japanese Facial Injectable Market
    • 1.2.5.3 Chinese and Taiwanese Facial Injectable Markets
  • 1.2.6 Market Drivers and Limiters
    • 1.2.6.1 Market Drivers
    • 1.2.6.2 Market Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Competitive Landscape
  • 1.3.2 Market Shares
  • 1.3.3 Competitor Discussions (in Alphabetical Order)
    • Allergan
    • GlaxoSmithKline
    • Ipsen
    • LIBP
    • Q-Med
    • Other

2.0 BOTULINUM TOXIN MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Product Overview
  • 2.2.2 Market Forecast
  • 2.2.3 Market Drivers and Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares

3.0 HYALURONIC ACID DERMAL FILLER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Product Overview
  • 3.2.2 Market Forecast
  • 3.2.3 Market Drivers and Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
  • 3.3.2 Market Shares

4.0 PARTICLE AND POLYMER FILLER MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Product Overview
  • 4.2.2 Market Forecast
  • 4.2.3 Market Drivers and Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares

5.0 COLLAGEN FILLER MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Product Overview
  • 5.2.2 Market Forecast
  • 5.2.3 Market Drivers and Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Competitive Landscape
  • 5.3.2 Market Shares

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

• EXECUTIVE SUMMARY
• Exhibit 1: Facial Injectable Market, Asia Pacific (US$), 2008 - 2014
• Exhibit 2: BTX and Dermal Filler Procedures, as a % of Total, Asia Pacific, 2009 and 2014
• Exhibit 3: HA Dermal Filler Sales, by Region, Asia Pacific, 2008 - 2014
• Exhibit 4: PPF Market, by Region, Asia Pacific (US$), 2008 - 2014
• Exhibit 5: Collagen Filler Market, Asia Pacific (US$), 2008 - 2014
• Exhibit 6: Leading Competitors in the Facial Injectable Market, Asia Pacific, 2009
• METHODOLOGY
• Exhibit 7: Currency Exchange Rates, 2009
• CHAPTER 1: ASIA PACIFIC FACIAL INJECTABLE MARKET
• Exhibit 8: Facial Injectable Market, by Region, Asia Pacific (US$), 2008 - 2014 (Graphical Format)
• Exhibit 9: Key Report Updates, 2010
• Exhibit 10: Key Report Updates, 2010 (Continued)
• Exhibit 11: Common Facial Aesthetic Indications, by Type, Asia Pacific, 2009
• Exhibit 12: Common Facial Injectable Products, Asia Pacific, 2009
• Exhibit 13: Volume per Procedure, by Product
• Exhibit 14: Facial Injectable Procedures, by Segment and Region, Asia Pacific, 2008 - 2014
• Exhibit 15: BTX Procedures, by Region, Asia Pacific, 2008 - 2014
• Exhibit 16: HA Dermal Filler Procedures, by Region, Asia Pacific, 2008 - 2014
• Exhibit 17: PPF Procedures, by Region, Asia Pacific, 2008 - 2014
• Exhibit 18: Collagen Dermal Filler Procedures, by Region, Asia Pacific, 2008 - 2014
• Exhibit 19: Facial Injectable Market, by Region, Asia Pacific (US$), 2008 - 2014 (Tabular Format)
• Exhibit 20: Facial Injectable Market, by Segment, Asia Pacific (US$) 2008 - 2014
• Exhibit 21: Facial Injectable Market, by Segment, Australasia (US$), 2008 - 2014
• Exhibit 22: Facial Injectable Market, by Segment, Australasia (AUD), 2008 - 2014
• Exhibit 23: Dermal Filler Market, by Segment, Australasia (US$), 2008 - 2014
• Exhibit 24: Dermal Filler Market, by Segment, Australasia (AUD), 2008 - 2014
• Exhibit 25: Facial Injectable Market, by Segment, Japan (US$), 2008 - 2014
• Exhibit 26: Facial Injectable Market, by Segment, Japan (¥), 2008 - 2014
• Exhibit 27: Dermal Filler Market, by Segment, Japan (US$), 2008 - 2014
• Exhibit 28: Dermal Filler Market, by Segment, Japan (¥), 2008 - 2014
• Exhibit 29: Facial Injectable Market, by Segment, China (US$), 2008 - 2014
• Exhibit 30: Facial Injectable Market, by Segment, China (CNY and HK$), 2008 - 2014
• Exhibit 31: Dermal Filler Market, by Segment, China (US$), 2008 - 2014
• Exhibit 32: Dermal Filler Market, by Segment, China (CNY and HK$), 2008 - 2014
• Exhibit 33: Facial Injectable Market, by Segment, Taiwan (US$), 2008 - 2014
• Exhibit 34: Facial Injectable Market, by Segment, Taiwan (NT$), 2008 - 2014
• Exhibit 35: Dermal Filler Market, by Segment, Taiwan (US$), 2008 - 2014
• Exhibit 36: Dermal Filler Market, by Segment, Taiwan (NT$), 2008 - 2014
• Exhibit 37: Drivers and Limiters of the Facial Injectable Market, Asia Pacific
• Exhibit 38: Leading Competitors in the Facial Injectable Market, by Segment, as a % of Total, Asia Pacific, 2009
• CHAPTER 2: BOTULINUM TOXIN MARKET
• Exhibit 39: BTX Market, by Region, Asia Pacific (US$), 2008 - 2014 (Graphical Format)
• Exhibit 40: Common Cosmetic BTX Products, Asia Pacific, 2009
• Exhibit 41: BTX Market, by Region, Asia Pacific (US$), 2008 - 2014 (Tabular Format)
• Exhibit 42: BTX Market, by Region, Asia Pacific (Local Currency), 2008 - 2014
• Exhibit 43: BTX Market Growth, by Region, Asia Pacific, 2009 - 2014
• Exhibit 44: Drivers of the BTX Market, Asia Pacific
• Exhibit 45: Limiters of the BTX Market, Asia Pacific
• Exhibit 46: Leading Competitors in the BTX Market, by Region, as a % of Total, Asia Pacific, 2009
• CHAPTER 3: HYALURONIC ACID DERMAL FILLER MARKET
• Exhibit 47: HA Dermal Filler Market, by Region, Asia Pacific (US$), 2008 - 2014 (Graphical Format)
• Exhibit 48: Common HA Dermal Filler Products, Asia Pacific, 2009
• Exhibit 49: HA Dermal Filler Market, by Region, Asia Pacific (US$), 2008 - 2014 (Tabular Format)
• Exhibit 50: HA Dermal Filler Market, by Region, Asia Pacific (Local Currency), 2008 - 2014
• Exhibit 51: HA Dermal Filler Market Growth, by Region, Asia Pacific, 2009 - 2014
• Exhibit 52: Drivers of the HA Dermal Filler Market, Asia Pacific
• Exhibit 53: Limiters of the HA Dermal Filler Market, Asia Pacific
• Exhibit 54: Leading Competitors in the HA Dermal Filler Market, by Region, as a % of Total, Asia Pacific, 2009
• CHAPTER 4: PARTICLE AND POLYMER FILLER MARKET
• Exhibit 55: PPF Market, Asia Pacific (US$), 2008 - 2014
• Exhibit 56: Common PPF Products, Asia Pacific, 2009
• Exhibit 57: PPF Market, by Region, Asia Pacific (US$), 2008 - 2014
• Exhibit 58: PPF Market, by Region, Asia Pacific (Local Currency), 2008 - 2014
• Exhibit 59: PPF Market Growth, by Region, Asia Pacific, 2009 - 2014
• Exhibit 60: Drivers of the PPF Market, Asia Pacific
• Exhibit 61: Limiters of the PPF Market, Asia Pacific
• Exhibit 62: Leading Competitors in the PPF Market, by Region, as a % of Total, Asia Pacific, 2009
• CHAPTER 5: COLLAGEN FILLER MARKET
• Exhibit 63: Collagen Market, Asia Pacific (US$), 2008 - 2014
• Exhibit 64: Common Collagen Products, Asia Pacific, 2009
• Exhibit 65: Collagen Filler Market, by Region, Asia Pacific (US$), 2008 - 2014
• Exhibit 66: Collagen Filler Market, by Region, Asia Pacific (Local Currency), 2008 - 2014
• Exhibit 67: Collagen Filler Market Growth, by Region, Asia Pacific, 2009 - 2014
• Exhibit 68: Drivers of the Collagen Filler Market, Asia Pacific
• Exhibit 69: Limiters of the Collagen Filler Market, Asia Pacific
• Exhibit 70: Leading Competitors in the Collagen Filler Market, by Region, as a % of Total, Asia Pacific, 2009
• APPENDIX B: SUPPLEMENTAL EXHIBITS
• Exhibit 71: Facial Injectable Market, Asia Pacific (US$), 2008 - 2014 (Detailed Format)
• Exhibit 72: BTX and Dermal Filler Procedures, as a % of Total, Asia Pacific, 2009 and 2014 (Detailed Format)
• Exhibit 73: HA Dermal Filler Sales, by Region, Asia Pacific, 2008 - 2014 (Detailed Format)
• Exhibit 74: PPF Market, by Region, Asia Pacific (US$), 2008 - 2014 (Detailed Format)
• Exhibit 75: Collagen Filler Market, Asia Pacific (US$), 2008 - 2014 (Detailed Format)

Related Reports